Skip to Main Content

Paper Details

Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.
Proc Natl Acad Sci U S A
86
2018
19-gene, CTC, CTCs, PD-1 ligand, PD-L1, blood cells, blood specimens, circulating melanoma cells, melanoma, melanoma CTC, melanoma cells, melanoma circulating tumor cells, metastatic melanoma, microfluidically, patient, patients, tumor, tumor biopsies
Author NameAffiliation
Lecia V SequistMassachusetts General Hospital Cancer Center, Harvard Medical School
Lecia V SequistMassachusetts General Hospital, Harvard Medical School
David T MiyamotoMassachusetts General Hospital Cancer Center, Harvard Medical School
David T MiyamotoMassachusetts General Hospital, Harvard Medical School
Michael S LawrenceMassachusetts General Hospital Cancer Center, Harvard Medical School
Mehmet TonerCenter for Bioengineering in Medicine, Massachusetts General Hospital and Shriners Hospital for Children, Harvard Medical School
Mehmet TonerMassachusetts General Hospital, Harvard Medical School
  • 1 - 7

Datasets

Release 1.2